Deciding on PSA-screening - Quality of current consumer information on the Internet

被引:9
|
作者
Korfage, Ida J. [1 ]
van den Bergh, Roderick C. N. [1 ,2 ]
Essink-Bot, Marie-Louise [3 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands
[2] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Inst Social Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Prostate cancer; PSA-test; Consumer information; Leaflet; Quality assessment; PROSTATE-CANCER; INFORMED CHOICE; PARTICIPATION; GUIDELINES; MORTALITY; PROGRAMS; AUTONOMY; LEAFLETS; TRIAL;
D O I
10.1016/j.ejca.2010.09.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of the study: Given that screening for prostate cancer has the potential to reduce prostate cancer mortality at the expense of considerable overdiagnosis and overtreatment, the availability of core consumer information - correct, balanced and supportive of autonomous decision-making - is a must. We assessed the quality of consumer information available through the Internet per November 2009 and its possible contribution to informed decision-making by potential screenees. Methods: Consumer information on PSA-screening was sought through the Internet in November 2009. Materials had to be targeted at potential consumers, offered by not-for-profit organisations, released in 2005 or after, in English or Dutch. Per material 2 of the authors assessed independently from each other whether standardised pre-defined topics were addressed, whether the content was correct and which approach was taken towards the decision-making process about uptake. Results: Twenty-three materials were included, of which 11 were released (shortly) after the results of 2 large randomized-controlled trials (RCTs) that evaluated the effectiveness of screening for prostate cancer had been published in March 2009. That a PSA-test result can be abnormal because of non-cancerous conditions (false positive) and that it may miss prostate cancer (false negative) was not addressed in 2/23 and 8/23 materials, respectively. The risk of overdiagnosis and overtreatment was not mentioned in 6 out of 23. PSA-screening was presented as a usual thing to do in some materials, whereas other materials emphasised the voluntary nature of PSA-screening (it is your decision'). The content of 19/23 materials was considered sufficiently informative according to the pre-defined criteria, 12/23 materials were considered supportive of informed decision-making by men. Conclusions: Most materials of not-for-profit organizations supplied adequate information about PSA-screening, whilst the degree of persuasion towards uptake reflected variations in opinions on men's autonomy regarding their own health. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3073 / 3081
页数:9
相关论文
共 50 条
  • [21] Risk-adapted PSA screening and the PROBASE trial [Risikoadaptiertes PSA-Screening und die PROBASE-Studie]
    Arsov C.
    Becker N.
    Albers P.
    Der Onkologe, 2015, 21 (9): : 778 - 786
  • [22] Prostate cancer detection rate at low PSA levels: Results from the Tyrol PSA-screening project
    Horninger, W
    Volgger, H
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    JOURNAL OF UROLOGY, 2002, 167 (04): : 324 - 325
  • [23] THE TRUE BENEFIT OF PSA-SCREENING: MODELING THE IMPACT OF TRIAL SETTING AND PROTOCOL ON MORTALITY
    Heijnsdijk, Eveline
    Wever, Elisabeth
    de Koning, Harry
    JOURNAL OF UROLOGY, 2012, 187 (04): : E588 - E588
  • [24] Statement of the German Society of Urology on IQWiG's final report "PSA-Screening"
    Michel, Maurice-Stephan
    Rassweiler, Jens
    Grimm, Marc-Oliver
    UROLOGE, 2020, 59 (07): : 870 - 870
  • [25] Impact of exposure rate of PSA-screening on clinical stage of prostate cancer in Japan
    Ito, K
    Yamamoto, T
    Takechi, H
    Suzuki, K
    JOURNAL OF UROLOGY, 2006, 175 (04): : 477 - 478
  • [26] PSA-Screening älterer Männer scheint gang und gäbe zu sein
    Robert Bublak
    MMW - Fortschritte der Medizin, 2023, 165 (10) : 20 - 20
  • [27] PSA-Screening und Tastuntersuchung bereits ab 40 empfohlenFrüherkennung des Prostatakarzinoms
    Yasemin Hocaoglu
    Michael Seitz
    Christian G. Seitz
    Patrick J. Bastian
    MMW - Fortschritte der Medizin, 2012, 154 (1) : 43 - 47
  • [28] PSA screening - current controversy
    Svetec, D
    Thompson, IM
    ANNALS OF ONCOLOGY, 1998, 9 (12) : 1283 - 1288
  • [29] Current PSA screening guidelines
    Cabarkapa, Sonja
    Perera, Marlon
    Lawrentschuk, Nathan
    BJU INTERNATIONAL, 2016, 118 : 15 - 15
  • [30] Medical Information on the Internet: A Tool for Measuring Consumer Perception of Quality Aspects
    Dubowicz, Arthur
    Schulz, Peter J.
    INTERACTIVE JOURNAL OF MEDICAL RESEARCH, 2015, 4 (01): : 82 - 93